SB 278
  • Introduced
    Jan 13, 2026
  • Passed Senate
  • Passed House
  • Became Law
SB 278
Virginia Senate Bill
Did you know we offer free bill tracking in Congress and 50 states, AI tools to streamline your work, and a great mobile app? Sign up here
Drug manufacturers; permitting and registration, certain conditions related to 340B-covered drugs.
Last Action See all actions
Senate • Jan 29, 2026: Reported from Education and Health with substitute and rereferred to Finance and Appropriations (9-Y 0-N 6-A)
Latest Bill Text See all bill texts
Education and Health Substitute

Summary

Comments on SB 278

Tweets

Whip Lists

Sponsors
Votes
Jan 29, 2026, Senate
Education and Health Reported from Education and Health with substitute and rereferred to Finance and Appropriations (9-Y 0-N 6-A)
YES: 9
NO: 0
OTHER: 6
YES: 9

NO: 0

    ABSTAIN: 6

    Sources
    Actions
    • Jan 29, 2026 | Senate
      • Senate committee offered
      • Reported from Education and Health with substitute and rereferred to Finance and Appropriations (9-Y 0-N 6-A)
    • Jan 28, 2026 | Senate
      • Senate subcommittee offered
    • Jan 27, 2026 | Senate
      • Fiscal Impact Statement from Department of Planning and Budget (SB278)
    • Jan 20, 2026 | Senate
      • Assigned Education sub: Health
    • Jan 13, 2026 | Senate
      • Prefiled and ordered printed; Offered 01-14-2026 26102079D
      • Referred to Committee on Education and Health
    Bill Texts
    Documents
    Sources